Genetic Technologies Limited (GNTLF)
USD 1.0
(0.0%)
USD 1.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 16.11 Million AUD | 30.99% |
| 2023 | 12.3 Million AUD | 295.64% |
| 2022 | 3.1 Million AUD | -55.59% |
| 2021 | 7 Million AUD | 16.06% |
| 2020 | 6.03 Million AUD | 2.07% |
| 2019 | 5.91 Million AUD | 0.75% |
| 2018 | 5.86 Million AUD | -26.87% |
| 2017 | 8.02 Million AUD | -7.2% |
| 2016 | 8.64 Million AUD | -20.52% |
| 2015 | 10.87 Million AUD | -13.54% |
| 2014 | 12.57 Million AUD | 18.94% |
| 2013 | 10.57 Million AUD | -30.82% |
| 2012 | 15.28 Million AUD | 0.63% |
| 2011 | 15.19 Million AUD | 509.93% |
| 2010 | -3.7 Million AUD | -118.36% |
| 2009 | 20.18 Million AUD | 20.2% |
| 2008 | 16.79 Million AUD | 91.9% |
| 2007 | 8.74 Million AUD | 9.37% |
| 2006 | 8 Million AUD | -36.61% |
| 2005 | 12.62 Million AUD | 52.98% |
| 2004 | 8.25 Million AUD | -39.29% |
| 2003 | 13.58 Million AUD | -38.19% |
| 2002 | 21.98 Million AUD | 142.56% |
| 2001 | 9.06 Million AUD | 32.83% |
| 2000 | 6.82 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 8.27 Million AUD | -32.76% |
| 2024 Q2 | 3.18 Million AUD | -33.79% |
| 2024 Q1 | 4.8 Million AUD | 43.08% |
| 2024 Q4 | 4.6 Million AUD | 0.0% |
| 2023 Q1 | 4.25 Million AUD | -41.28% |
| 2023 Q3 | 4.8 Million AUD | 24.97% |
| 2023 Q2 | 3.84 Million AUD | -9.55% |
| 2023 FY | 12.3 Million AUD | 295.64% |
| 2023 Q4 | 3.35 Million AUD | -30.09% |
| 2022 Q3 | 3.58 Million AUD | -37.25% |
| 2022 Q1 | 3.1 Million AUD | -18.48% |
| 2022 FY | 3.1 Million AUD | -55.59% |
| 2022 Q2 | 5.71 Million AUD | 83.78% |
| 2022 Q4 | 7.23 Million AUD | 101.91% |
| 2021 Q4 | 3.81 Million AUD | 52.97% |
| 2021 Q1 | 1.65 Million AUD | -57.94% |
| 2021 Q2 | 4.17 Million AUD | 152.94% |
| 2021 Q3 | 2.49 Million AUD | -40.28% |
| 2021 FY | 7 Million AUD | 16.06% |
| 2020 Q1 | 1.22 Million AUD | -60.74% |
| 2020 Q2 | 2.88 Million AUD | 135.61% |
| 2020 Q3 | 1.78 Million AUD | -37.95% |
| 2020 Q4 | 3.92 Million AUD | 119.4% |
| 2020 FY | 6.03 Million AUD | 2.07% |
| 2019 Q4 | 3.11 Million AUD | 99.17% |
| 2019 Q1 | 1.52 Million AUD | 46.36% |
| 2019 Q2 | 1.52 Million AUD | 0.0% |
| 2019 FY | 5.91 Million AUD | 0.75% |
| 2019 Q3 | 1.56 Million AUD | 2.53% |
| 2018 Q3 | 1.04 Million AUD | -35.93% |
| 2018 Q1 | 1.62 Million AUD | -23.71% |
| 2018 FY | 5.86 Million AUD | -26.87% |
| 2018 Q2 | 1.62 Million AUD | 0.0% |
| 2018 Q4 | 1.04 Million AUD | 0.0% |
| 2017 Q2 | 2.08 Million AUD | -0.0% |
| 2017 FY | 8.02 Million AUD | -7.2% |
| 2017 Q4 | 2.13 Million AUD | 0.0% |
| 2017 Q3 | 2.13 Million AUD | 2.27% |
| 2017 Q1 | 2.08 Million AUD | -0.18% |
| 2016 Q3 | 2.08 Million AUD | -5.03% |
| 2016 Q4 | 2.08 Million AUD | 0.0% |
| 2016 Q2 | 2.2 Million AUD | -0.0% |
| 2016 Q1 | 2.2 Million AUD | 0.63% |
| 2016 FY | 8.64 Million AUD | -20.52% |
| 2015 FY | 10.87 Million AUD | -13.54% |
| 2015 Q4 | 2.18 Million AUD | 0.0% |
| 2015 Q3 | 2.18 Million AUD | -10.73% |
| 2015 Q2 | 2.44 Million AUD | 0.0% |
| 2015 Q1 | 2.44 Million AUD | -19.76% |
| 2014 Q4 | 3.05 Million AUD | 0.0% |
| 2014 FY | 12.57 Million AUD | 18.94% |
| 2014 Q1 | 2.52 Million AUD | -7.78% |
| 2014 Q2 | 2.52 Million AUD | -0.0% |
| 2014 Q3 | 3.05 Million AUD | 20.89% |
| 2013 FY | 10.57 Million AUD | -30.82% |
| 2013 Q4 | 2.73 Million AUD | 0.0% |
| 2013 Q3 | 2.73 Million AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | 15.28 Million AUD | 0.63% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 15.19 Million AUD | 509.93% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | -3.7 Million AUD | -118.36% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | 20.18 Million AUD | 20.2% |
| 2008 FY | 16.79 Million AUD | 91.9% |
| 2008 Q2 | 3.71 Million AUD | 0.0% |
| 2008 Q1 | - AUD | 100.0% |
| 2008 Q4 | -17.68 Million AUD | 0.0% |
| 2008 Q3 | - AUD | -100.0% |
| 2007 Q1 | - AUD | 100.0% |
| 2007 FY | 8.74 Million AUD | 9.37% |
| 2007 Q2 | 3.82 Million AUD | 0.0% |
| 2007 Q3 | - AUD | -100.0% |
| 2007 Q4 | -15.31 Million AUD | 0.0% |
| 2006 FY | 8 Million AUD | -36.61% |
| 2006 Q1 | - AUD | 100.0% |
| 2006 Q2 | 4.1 Million AUD | 0.0% |
| 2006 Q3 | - AUD | -100.0% |
| 2006 Q4 | -16.06 Million AUD | 0.0% |
| 2005 Q2 | 2.46 Million AUD | 0.0% |
| 2005 FY | 12.62 Million AUD | 52.98% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | -100.0% |
| 2005 Q4 | -17.23 Million AUD | 0.0% |
| 2004 FY | 8.25 Million AUD | -39.29% |
| 2003 FY | 13.58 Million AUD | -38.19% |
| 2002 FY | 21.98 Million AUD | 142.56% |
| 2001 FY | 9.06 Million AUD | 32.83% |
| 2000 FY | 6.82 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -1436.195% |
| Arrayit Corporation | 6.19 Million USD | -160.016% |
| Atlantic International Corp. | 5.57 Million USD | -188.883% |
| Biocept, Inc. | 29.4 Million USD | 45.19% |
| Bioqual, Inc. | 7.44 Million USD | -116.34% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -1987.011% |
| DermTech, Inc. | 104.01 Million USD | 84.507% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 90.322% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 28.771% |
| iMD Companies, Inc. | 151.8 Thousand USD | -10515.106% |
| IDenta Corp. | 662.97 Thousand USD | -2330.663% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 20.351% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -41346.172% |
| InVitro International | 661.32 Thousand USD | -2336.731% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -127.031% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -27630.393% |
| Medical Imaging Corp. | 1.91 Million USD | -742.746% |
| NovelStem International Corp. | 3.53 Million USD | -355.5% |
| Optigenex Inc. | 1.28 Million USD | -1151.267% |
| PharmChem, Inc. | 2.93 Million USD | -449.759% |
| Proteome Sciences plc | 3.26 Million USD | -393.105% |
| Response Genetics, Inc | 25.31 Million USD | 36.353% |
| Rennova Health, Inc. | 7.67 Million USD | -109.887% |
| RushNet, Inc. | 1.78 Million USD | -800.604% |
| ScreenPro Security Inc. | 3.23 Million USD | -397.534% |
| Stella Diagnostics Inc. | 11.42 Million USD | -41.024% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -119.456% |
| Todos Medical Ltd. | 14.05 Million USD | -14.63% |